A new study suggests that men could be spared some long-term toxic side effects without compromising the effectiveness of treatment by halving the amount of chemotherapy they receive after surgery.
A new study suggests that men could be spared some long-term toxic side effects without compromising the effectiveness of treatment by halving the amount of chemotherapy they receive after surgery.